Precision BioSciences Inc (DTIL)
9.60
-0.12
(-1.23%)
USD |
NASDAQ |
Apr 26, 12:24
Precision BioSciences Enterprise Value: -27.04M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | -27.04M |
| April 24, 2024 | -26.35M |
| April 23, 2024 | -23.51M |
| April 22, 2024 | -27.32M |
| April 19, 2024 | -26.90M |
| April 18, 2024 | -20.12M |
| April 17, 2024 | -14.66M |
| April 16, 2024 | -5.254M |
| April 15, 2024 | -3.940M |
| April 12, 2024 | 3.391M |
| April 11, 2024 | 5.673M |
| April 10, 2024 | 3.322M |
| April 09, 2024 | 1.454M |
| April 08, 2024 | -0.6898M |
| April 05, 2024 | 4.428M |
| April 04, 2024 | 4.912M |
| April 03, 2024 | 12.52M |
| April 02, 2024 | 3.944M |
| April 01, 2024 | 12.04M |
| March 28, 2024 | -0.4823M |
| March 27, 2024 | -4.494M |
| March 26, 2024 | -6.084M |
| March 25, 2024 | -12.65M |
| March 22, 2024 | -13.90M |
| March 21, 2024 | -11.55M |
| Date | Value |
|---|---|
| March 20, 2024 | -13.99M |
| March 19, 2024 | -15.50M |
| March 18, 2024 | -17.27M |
| March 15, 2024 | -20.29M |
| March 14, 2024 | -22.65M |
| March 13, 2024 | -18.32M |
| March 12, 2024 | -15.43M |
| March 11, 2024 | -17.60M |
| March 08, 2024 | -15.43M |
| March 07, 2024 | -11.76M |
| March 06, 2024 | -12.22M |
| March 05, 2024 | -14.12M |
| March 04, 2024 | -43.47M |
| March 01, 2024 | -42.57M |
| February 29, 2024 | -19.08M |
| February 28, 2024 | -18.84M |
| February 27, 2024 | -29.08M |
| February 26, 2024 | -29.24M |
| February 23, 2024 | -40.26M |
| February 22, 2024 | -44.81M |
| February 21, 2024 | -44.04M |
| February 20, 2024 | -41.64M |
| February 16, 2024 | -46.11M |
| February 15, 2024 | -47.12M |
| February 14, 2024 | -45.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-89.17M
Minimum
Mar 24 2023
798.29M
Maximum
Feb 08 2021
192.31M
Average
173.57M
Median
Aug 25 2020
Enterprise Value Benchmarks
| Altimmune Inc | 312.63M |
| BioVie Inc | 9.462M |
| Adial Pharmaceuticals Inc | 4.188M |
| Gritstone Bio Inc | 35.84M |
| Humacyte Inc | 422.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.29M |
| Revenue (Quarterly) | 7.038M |
| Total Expenses (Quarterly) | 21.93M |
| EPS Diluted (Quarterly) | -3.912 |
| Profit Margin (Quarterly) | -231.4% |
| Earnings Yield | -165.7% |
| Normalized Earnings Yield | -169.16 |